title: Marathon run under chemotherapy: is it possible?
authors.affiliation: Department of Sports Medicine, Goethe University Frankfurt/Main, Germany. m.bernhoerster@sport.uni-frankfurt.de
authors.forename: Marcus
authors.initials: M
authors.lastname: Bernhörster
authors.forename: Andreas
authors.initials: A
authors.lastname: Rosenhagen
authors.forename: Lutz
authors.initials: L
authors.lastname: Vogt
authors.forename: Christian
authors.initials: C
authors.lastname: Thiel
authors.forename: Elke
authors.initials: E
authors.lastname: Jäger
authors.forename: Winfried
authors.initials: W
authors.lastname: Banzer
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001761:Bleomycin / Q000627:therapeutic use; D003606:Dacarbazine / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D005260:Female; D006689:Hodgkin Disease / Q000188:drug therapy*; D006801:Humans; D012420:Running; D014747:Vinblastine / Q000627:therapeutic use
chemical_list: D001761:Bleomycin; D014747:Vinblastine; D003606:Dacarbazine; D004317:Doxorubicin